Hungarys' Richter revises 2019 estimates higher

Management turn more upbeat

Hungary Richter seen reporting record quarterly revenue

Profit expected to jump from low base

Hungary's Richter signs license and development agreement with Mycovia

For RVVC drug VT-1161

ANALYST VIEW - Jefferies sharply raises target price for Hungary's Richter

Rating upgraded to 'Buy' from 'Underperform'

Richter announces approval in Japan of its licensed-out biosimilar teriparatide

Hungarian drugmaker Richter projects slight growth in sales this year

With a 10% decrease in Russia and 20% in China

Vraylar sales in U.S. boost Richter Q2 result

Revenue rose 8.5% to HUF 120 billion.

Richter expected to post higher revenue, lower profit in Q2

Analysts forecast 30% lower net profit.

Drug makers could pay Hungary central budget HUF 100 bn in 2020

Hungary's Richter inks exclusive license deal for Australia, New Zealand

Richter to supply, Seqirus to sell.

Hungary Richter profit leaps in the first quarter of 2019

Revenues and profit overshoot estimates.

Hungary's Richter to report impressive profit growth for Q1

Earnings report to be released on 10 May.

Hungary's Richter buys minority stake in U.S. company

Via convertible notes.

Hungary Richter to pay HUF 100 dividend per share

From 2018 profits. Invitation for AGM shows.

Homeopathy is ineffective, pharmacies need to inform buyers in Hungary

Life is hard.

Hungary Richter quarterly profit plummets

One-off item dents profits.

Change in the executive management of Hungary's Richter

New technical director to be appointed.

Egis expands is plant in Körmend Hungary

With EUR 25 million investment.

Hungary Richter reports double-digit drop in Q3 after-tax profit

Drop in Esmya sales weigh on results.

Hungary's Richter receives good news

Pharmafarm is back in business.